|
FAM48A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.969200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.019200E-03 |
| Normal-vs-Stage2 |
5.638100E-03 |
| Normal-vs-Stage3 |
1.410060E-02 |
| Normal-vs-Stage4 |
5.363500E-03 |
| Stage1-vs-Stage2 |
1.490590E-01 |
| Stage1-vs-Stage3 |
7.979800E-01 |
| Stage1-vs-Stage4 |
3.157000E-01 |
| Stage2-vs-Stage3 |
2.278000E-01 |
| Stage2-vs-Stage4 |
4.758600E-01 |
| Stage3-vs-Stage4 |
5.233000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.883000E-03 |
| Normal-vs-AfricanAmerican |
6.879800E-03 |
| Normal-vs-Asian |
1.32860000778834E-09 |
| Caucasian-vs-AfricanAmerican |
2.614200E-01 |
| Caucasian-vs-Asian |
1.190870E-04 |
| AfricanAmerican-vs-Asian |
2.656100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.843400E-03 |
| Normal-vs-Female |
5.91610000000298E-05 |
| Male-vs-Female |
1.271960E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.786000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.23830000004133E-06 |
| Normal-vs-Age(61-80Yrs) |
3.247700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.271600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.466600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.778200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.653800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.724600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.947600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.272200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.55386999999285E-05 |
| Normal-vs-Grade 2 |
7.70130000000702E-05 |
| Normal-vs-Grade 3 |
2.996200E-02 |
| Normal-vs-Grade 4 |
4.670000E-02 |
| Grade 1-vs-Grade 2 |
2.410000E-02 |
| Grade 1-vs-Grade 3 |
7.819300E-03 |
| Grade 1-vs-Grade 4 |
1.274490E-02 |
| Grade 2-vs-Grade 3 |
3.221500E-02 |
| Grade 2-vs-Grade 4 |
4.309000E-01 |
| Grade 3-vs-Grade 4 |
5.413600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.75680000000078E-05 |
| Normal-vs-ccB subtype |
2.186200E-02 |
| ccA subtype-vs-ccB subtype |
1.391840E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.644900E-04 |
| Normal-vs-N1 |
5.180500E-02 |
| N0-vs-N1 |
9.911600E-01 |
|
|
